Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Seaport Therapeutics (NASDAQ:SPTX) through any online brokerage.
Other companies in Seaport Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Seaport Therapeutics has a consensus price target of $37.25.
The stock price for Seaport Therapeutics (NASDAQ: SPTX) is $19.73 last updated October 21, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Seaport Therapeutics.
Seaport Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Seaport Therapeutics.
Seaport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.